chr2-165913624-T-G
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS1
The NM_024753.5(TTC21B):c.2161A>C(p.Asn721His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000218 in 1,613,014 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_024753.5 missense
Scores
Clinical Significance
Conservation
Publications
- nephronophthisis 12Inheritance: AD, AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
- asphyxiating thoracic dystrophy 4Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Jeune syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- nephronophthisis 2Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TTC21B | NM_024753.5 | c.2161A>C | p.Asn721His | missense_variant | Exon 16 of 29 | ENST00000243344.8 | NP_079029.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TTC21B | ENST00000243344.8 | c.2161A>C | p.Asn721His | missense_variant | Exon 16 of 29 | 1 | NM_024753.5 | ENSP00000243344.7 |
Frequencies
GnomAD3 genomes AF: 0.00116 AC: 177AN: 152156Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000343 AC: 86AN: 250766 AF XY: 0.000170 show subpopulations
GnomAD4 exome AF: 0.000120 AC: 175AN: 1460740Hom.: 1 Cov.: 31 AF XY: 0.0000826 AC XY: 60AN XY: 726780 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00116 AC: 176AN: 152274Hom.: 0 Cov.: 32 AF XY: 0.00107 AC XY: 80AN XY: 74464 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:1
DNA sequence analysis of the TTC21B gene demonstrated a sequence change, c.2161A>C, in exon 16 that results in an amino acid change, p.Asn721His. This sequence change does not appear to have been previously described in individuals with TTC21B-related. This sequence change has been described in the gnomAD database with a frequency of 0.44% in the African subpopulation and 0.042% in the overall population (dbSNP rs146637219). The p.Asn721His change affects a poorly conserved amino acid residue located in a domain of the TTC21B protein that is known to be functional. In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL) provide contradictory results for the p.Asn721His substitution. Due to insufficient evidences and the lack of functional studies, the clinical significance of the p.Asn721His change remains unknown at this time.
Jeune thoracic dystrophy;C0687120:Nephronophthisis Benign:1
not provided Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at